Haleon (NYSE:HLN) Rating Lowered to Equal Weight at Morgan Stanley

Haleon (NYSE:HLN) was downgraded by stock analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a report issued on Friday,Briefing.com Automated Import reports.

Other equities analysts have also issued research reports about the stock. UBS Group raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Stock Up 0.4 %

Shares of HLN stock opened at $9.50 on Friday. The stock’s 50 day simple moving average is $9.61 and its 200 day simple moving average is $9.67. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The company has a market capitalization of $43.00 billion, a price-to-earnings ratio of 27.94, a PEG ratio of 2.95 and a beta of 0.29.

Institutional Investors Weigh In On Haleon

Several hedge funds and other institutional investors have recently modified their holdings of the stock. AE Wealth Management LLC increased its holdings in shares of Haleon by 6.1% during the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock worth $159,000 after purchasing an additional 1,098 shares during the period. Lake Street Advisors Group LLC increased its stake in Haleon by 5.4% during the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock valued at $237,000 after acquiring an additional 1,143 shares during the period. Synovus Financial Corp raised its holdings in Haleon by 0.8% in the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after acquiring an additional 1,216 shares in the last quarter. Hexagon Capital Partners LLC lifted its position in shares of Haleon by 18.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock worth $84,000 after acquiring an additional 1,238 shares during the period. Finally, Brown Brothers Harriman & Co. grew its holdings in shares of Haleon by 21.4% during the 2nd quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company’s stock worth $63,000 after purchasing an additional 1,334 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.